Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Letter to the Editor
  • Published:

Development of echinocandin resistance in Candida krusei isolates following exposure to micafungin and caspofungin in a BM transplant unit

This is a preview of subscription content, access via your institution

Relevant articles

Open Access articles citing this article.

Access options

Rent or buy this article

Prices vary by article type

from$1.95

to$39.95

Prices may be subject to local taxes which are calculated during checkout

References

  1. Goodman JL, Winston DJ, Greenfield RA, Chandrasehar PH, Fox B, Kaizer H et al. A controlled trial of fluconazole to prevent fungal infections in patients undergoing bone marrow transplantation. N Engl J Med 1992; 326: 845–851.

    Article  CAS  Google Scholar 

  2. van Burik JAH, Ratanatharathorn V, Stepan DE, Miller CB, Lipton JH, Vesole DH et al. Micafungin versus fluconazole for prophylaxis against invasive fungal infections during neutropenia in patients undergoing hematopoietic stem cell transplantation. Clin Infect Dis 2004; 39: 1407–1416.

    Article  CAS  Google Scholar 

  3. Pfaller MA, Messer MA, Moet GJ, Jones RN, Castanheira M . Candida bloodstream infections: comparison of species distribution and resistance to echinocandin and azole antifungal agents in intensive care unit (ICU) and non-ICU settings in the SENTRY antimicrobial surveillance program (2008-2009). Int J Antimicrob Agents 2011; 38: 65–69.

    Article  CAS  Google Scholar 

  4. Hakki M, Staab JF, Marr KA . Emergence of a Candida krusei isolate with reduced susceptibility to caspofungin during therapy. Antimicrob Agents Chemother 2006; 50: 2522–2524.

    Article  CAS  Google Scholar 

  5. Park S, Kelly R, Kahn JN, Robles J, Hsu MJ, Register E et al. Specific substitutions in the echinocandin target FKS1p account for reduced susceptibility of rare laboratory and clinical Candida sp. isolates. Antimicrob Agents Chemother 2005; 49: 3264–3273.

    Article  CAS  Google Scholar 

  6. EUCAST.. EUCAST definitive document EDef 7.1: method for the determination of broth dilution MICs of antifungal agents for fermentative yeasts. Clin Microbiol Infect 2008; 14: 398–405.

    Article  Google Scholar 

  7. Desnos-Ollivier M, Bretagne S, Raoux D, Hoinard D, Dromer F, Dannaoui E . Mutations in the fks1 gene in Candida albicans C. tropicalis, and C. krusei correlate with elevated caspofungin MICs uncovered in AM3 medium using the method of the European Committee on Antibiotic Susceptibility Testing. Antimicrob Agents Chemother 2008; 52: 3092–3098.

    Article  CAS  Google Scholar 

  8. Jacobsen MD, Gow NA, Maiden MC, Shaw DJ, Odds FC . Strain typing and determination of population structure of Candida krusei by multilocus sequence typing. J Clin Microbiol 2007; 45: 317–323.

    Article  CAS  Google Scholar 

  9. Pfaller MA, Diekema DJ, Andes D, Arendrup MC, Brown SD, Lockhart SR et al. Clinical breakpoints for the echinocandins and Candida revisited: integration of molecular, clinical, and microbiological data to arrive at species-specific interpretive criteria. Drug Resist Updat 2011; 14: 164–176.

    Article  CAS  Google Scholar 

  10. Shah DN, Yau R, Lasco TM, Weston J, Salazar M, Palmer HR et al. Impact of prior inappropriate fluconazole dosing on isolation of fluconazole-nonsusceptible Candida species in hospitalized patients with candidemia. Antimicrob Agents Chemother 2012; 56: 3239–3243.

    Article  CAS  Google Scholar 

Download references

Acknowledgements

We thank Catherine Blanc and Damien Hoinard for technical assistance. We thank the Platform Genotyping of Pathogen and Public Health, Institut Pasteur, for sequencing facility.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to E Tavernier.

Ethics declarations

Competing interests

The authors declare no conflict of interest.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Tavernier, E., Desnos-Ollivier, M., Honeyman, F. et al. Development of echinocandin resistance in Candida krusei isolates following exposure to micafungin and caspofungin in a BM transplant unit. Bone Marrow Transplant 50, 158–160 (2015). https://doi.org/10.1038/bmt.2014.230

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/bmt.2014.230

This article is cited by

Search

Quick links